About
CNS small molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Team (10)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
394
By Phase
PHASE3: 1PHASE1: 1
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06553027Lead Sponsor
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
PHASE3Recruiting
330 participants
Started: Sep 20, 2024 · Completed: Mar 31, 2026
NCT05105243Lead Sponsor
Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers
PHASE1Completed
64 participants
Started: Jan 17, 2022 · Completed: Nov 21, 2022
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...